Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase III Uncontrolled Open-label Trial to Evaluate Safety and Efficacy of BAY81-8973 in Children With Severe Hemophilia A Under Prophylaxis Therapy

NCT01311648 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01311648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01311648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase III Uncontrolled Open-label Trial to Evaluate Safety and Efficacy of BAY81-8973 in Children With Severe Hemophilia A Under Prophylaxis Therapy
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
June 9, 2011
Completion date
October 27, 2020
Enrollment
94 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilia a